Senior Leadership

高层领导

• 批准号: 7944846
• 负责人: ROBERT B. DIASIO
• 金额: $ 52.23万
• 依托单位: MAYO CLINIC ROCHESTER
• 依托单位国家: 美国
• 财政年份: 2009
• 资助国家: 美国
• 起止时间: 2009-04-17 至 2014-02-28
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7944846
• 关键词: Appointment; Arizona; Basic Science; Cancer Center; Cancer Center Support Grant; Clinic; Clinical; Clinical Research; Comprehensive Cancer Center; Florida; Grant; Hematologic Neoplasms; Leadership; Mayo Clinic Cancer Center; Population Sciences; Positioning Attribute; Recruitment Activity; Research; Research Activity; Site; Training and Education; Translational Research; cancer research center director; programs

Mayo Clinic Cancer Center (MCCC) Senior Leadership encompasses the Director, Deputy Director Clinical Affairs, Deputy Director MCCC Arizona, Deputy Director MCCC Florida, and 5 Associate Directors. There have been a number of changes since the last renewal. As part of a planned succession following the successful 2003 CCSG competitive renewal, Dr. Robert Diasio was recruited as Cancer Center Director in a national search initiated in mid 2005 culminating with his appointment effective September 1, 2006. Dr. Charles Erlichman, previously an MCCC Associate Director, was appointed Deputy Director for Clinical Affairs in late 2004. In his position as Deputy Director for Clinical Affairs, he has primary responsibility for overseeing and implementing integration of the Cancer Center's clinical research activities across all three sites. Also in late 2004, Dr. Robert Smallridge was formally appointed as Deputy Director for MCCC Florida; having previously been the acting Deputy Director. Dr. Rafael Fonseca, co-program leader of the Hematologic Malignancies Program, was appointed as Deputy Director for MCCC Arizona in July 2006 succeeding Dr. Laurence J. Miller who stepped down to focus on his responsibilities as Associate Dean for Research at Mayo Clinic and Director for Research at Mayo Clinic Arizona. Senior Leadership otherwise remains unchanged at the level of the Associate Directors with Dr. Ed Leof continuing as Associate Director for Basic Sciences, Dr. Gloria Petersen as Associate Director for Population Sciences, Dr. Robert Jenkins as Associate Director for Translational Research, Mr. Michael Pfenning as Associate Director for Administration and Dr. Lynn Hartmann as Associate Director for Education and Training. SENIOR/

梅奥临床癌症中心(MCCC)高级领导包括临床主任、副主任 亚利桑那州MCCC副主任、佛罗里达州MCCC副主任和5名副主任。 自上次续签以来，已经发生了一些变化。作为以下计划继任的一部分 2003年CCSG成功更新竞争对手，Robert Diasio博士被聘为癌症中心 在2005年年中开始的全国范围内寻找主任，最终他的任命在9月1日生效， 2006年。查尔斯·埃利希曼博士，以前是MCCC的副主任，被任命为 2004年底的临床事务。在他担任临床事务副主任的职位上，他有主要的 负责监督和实施癌症中心临床研究活动的整合 在所有三个地点。同样在2004年底，罗伯特·斯莫里奇博士被正式任命为副主任 为佛罗里达MCCC工作；之前曾担任代理副主任。Rafael Fonseca博士，联合项目 年，血液恶性肿瘤项目负责人被任命为亚利桑那州MCCC副主任 2006年7月接替劳伦斯·J·米勒博士，后者卸任，专注于 梅奥诊所研究副院长和亚利桑那州梅奥诊所研究主任。 高级领导层在其他方面与Ed Leof博士保持在副主任级别不变 继续担任基础科学副主任，Gloria Petersen博士担任 人口科学，Robert Jenkins博士担任翻译研究副主任Michael先生 Pfenning为行政副主任，Lynn Hartmann博士为副主任 教育和培训。 资深/